Psoriasis or psoriasis arthropathy
Inflammatory bowel disease
Unwillingness to participate in the study with additional imaging protocols
Expected life-span less than <1 year
Diabetes (to improve the PET imaging quality)
Probable noncompliance
Pregnancy
Age <18 years or >75 years
Contraindication for adalimumab
Methotrexate used within the previous 6 months
A biologic medicine used within the previous 6 months

NCT02634541_exc_T1
Condition
Psoriasis
NCT02634541_exc_T3
Condition
psoriasis arthropathy
NCT02634541_exc_T2
Condition
Inflammatory bowel disease
NCT02634541_exc_T5
Observation
Expected life-span
NCT02634541_exc_T6
Value
less than <1 year
NCT02634541_exc_T7
Condition
Diabetes
NCT02634541_exc_T8
Procedure
PET imaging quality
NCT02634541_exc_T9
Qualifier
Probable
NCT02634541_exc_T10
Condition
noncompliance
NCT02634541_exc_T11
Condition
Pregnancy
NCT02634541_exc_T12
Person
Age
NCT02634541_exc_T13
Value
<18 years
NCT02634541_exc_T14
Value
>75 years
NCT02634541_exc_T15
Scope
<18 years or >75 years
NCT02634541_exc_T16
Condition
Contraindication
NCT02634541_exc_T17
Drug
adalimumab
NCT02634541_exc_T18
Drug
Methotrexate
NCT02634541_exc_T19
Temporal
within the previous 6 months
NCT02634541_exc_T20
Drug
biologic medicine
NCT02634541_exc_T21
Temporal
within the previous 6 months